Metabolic effects of Diabecinn (oral cinnamon extract) in diabetes type 2, a placebo-controlled randomized clinical trial

Completed

• Conditions: Diabetes Mellitus type 2 (DM type II); Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN36704940
• Lead Sponsor: Academic Medical Center (AMC) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. Type 2 diabetes patients
2. Age 35-70 years inclusive
3. HbA1c between 7 and 12% inclusive

Exclusion Criteria

1. Pregnancy
2. Breast-feeding

Study & Design

• Study Type: Interventional
• Study Design: Not specified